Author: Oliver J.M. Kepley C.L. Ortega E. Wilson B.S.
Publisher: Elsevier
ISSN: 0162-3109
Source: Immunopharmacology, Vol.48, Iss.3, 2000-07, pp. : 269-281
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Ras Signaling Pathway Proteins as Therapeutic Targets
Current Pharmaceutical Design, Vol. 7, Iss. 16, 2001-11 ,pp. :
By Vannacci A. Baronti R. Zagli G. Marzocca C. Pierpaoli S. Bani D. Passani M.B. Mannaioni P.F. Masini E.
European Journal of Pharmacology, Vol. 465, Iss. 3, 2003-04 ,pp. :
Mast Cells in Allergic and Inflammatory Diseases
Current Pharmaceutical Design, Vol. 18, Iss. 16, 2012-06 ,pp. :
CYLD-Mediated Signaling and Diseases
Current Drug Targets, Vol. 16, Iss. 4, 2015-04 ,pp. :